Non-Invasive Prenatal Diagnosis of Monogenic Disorders Through Bayesian- and Haplotype-Based Prediction of Fetal Genotype

Jia Li, Jiaqi Lu, Fengxia Su, Jiexia Yang, Jia Ju, Yu Lin, Jinjin Xu, Yiming Qi, Yaping Hou, Jing Wu, Wei He, Zhengtao Yang, Yujing Wu, Zhuangyuan Tang, Ying‐Ping Huang, Guohong Zhang, Ying Yang, Long Zhou, Xiaofang Cheng, Ping Liu, Jun Xia, Yanyan Zhang, Yicong Wang, Fang Chen, Jianguo Zhang, Lijian Zhao, Xin Jin, Ya Gao, Aihua YinFrontiers in Genetics 2022 · DOI

TL;DR

This paper introduces a novel combined Bayesian and haplotype-based method for non-invasively predicting fetal genotypes from maternal plasma DNA. This approach significantly improves accuracy in identifying single nucleotide variations (SNVs) and insertions/deletions (InDels), paving the way for more reliable prenatal diagnosis of monogenic disorders.

What Problem Does This Paper Address?

Non-invasive prenatal diagnosis (NIPD) offers a low-risk way to detect genetic disorders during pregnancy. However, existing methods often struggle with accurately inferring fetal genotypes, especially at heterozygous loci or when parental haplotype information is incomplete. This limitation hinders the ability to diagnose a wide range of monogenic diseases, particularly those not caused by common mutations or those with de novo variants. Furthermore, some methods require proband DNA, which may not be available, or have limited accuracy in complex genetic scenarios. This study aims to overcome these limitations by developing a more robust method that leverages both maternal plasma cell-free DNA (cfDNA) and parental genomic DNA.

Methods

The researchers developed a two-pronged approach:

  1. Bayesian Model: This model uses maternal plasma cfDNA and parental genomic DNA to infer fetal genotypes. It calculates the probability of different maternal and fetal genotype combinations based on read depth, fetal fraction (FF), and Mendelian inheritance laws.
  2. Haplotype-Based Method: This method leverages long-range phasing of parental genomic DNA to reconstruct parental haplotypes. This is crucial for accurately determining which parental allele is inherited by the fetus, especially at heterozygous loci.

The core innovation lies in combining these two methods. The Bayesian model is used for certain loci (e.g., homozygous maternal, heterozygous paternal), while the haplotype-based method handles more complex scenarios (e.g., heterozygous maternal and paternal). This synergistic approach aims to fill in the gaps left by each individual method, leading to a more comprehensive and accurate fetal genotype prediction. They also employed specialized algorithms like Sequential Probability Ratio Testing (SPRT) and "closest-variant" algorithms to infer parental contributions.

Datasets

The study utilized samples from two groups of participants:

  • Healthy Pregnancies: Five couples with healthy singleton pregnancies were recruited. Their maternal plasma cfDNA and parental genomic DNA were sequenced. Umbilical cord blood was collected post-delivery for validation.
  • High-Risk Pregnancies: Five additional couples whose fetuses were at risk for specific monogenic diseases were recruited. Amniocentesis was performed for prenatal diagnosis, and parental genomic DNA was Sanger-sequenced to confirm disease variants.

The cfDNA was sequenced using whole-genome sequencing (WGS) and the parental genomic DNA using single-tube long fragment reads (stLFR) sequencing.

Key Insights and Ideas

  • Synergy is Key: The most significant insight is that combining Bayesian inference with haplotype-based phasing dramatically improves fetal genotype prediction accuracy, especially for complex heterozygous loci where individual methods falter.
  • Haplotype Resolution Matters: The use of stLFR sequencing allowed for longer-range haplotype phasing, which is critical for accurate inference, outperforming previous methods that relied on shorter haplotype blocks.
  • Fetal Fraction is a Hurdle, But Not Insurmountable: While a higher fetal fraction (FF) generally leads to better accuracy, the combined method demonstrated impressive performance even at very low FF (as low as 4%), suggesting its potential for early pregnancy diagnosis.
  • Beyond SNVs: The method's ability to accurately detect both SNVs and InDels is a significant step forward, as InDels are often challenging to call.

Key Results

The combined method achieved high accuracies in predicting fetal genotypes:

  • SNVs:
    • Maternal homozygous and paternal heterozygous loci (AAAB): 96.2 ± 5.8%
    • Maternal heterozygous and paternal homozygous loci (ABAA): 96.2 ± 1.4%
    • Maternal heterozygous and paternal heterozygous loci (ABAB): 87.2 ± 4.7%
  • InDels:
    • AAAB loci: 94.6 ± 1.9%
    • ABAA loci: 80.2 ± 4.3%
    • ABAB loci: 79.3 ± 3.3%
  • Monogenic Disease Diagnosis: In five fetuses at risk for monogenic diseases, the approach detected pathogenic variants with an accuracy of 87.5%.

Limitations and Future Work

The authors acknowledge several limitations and suggest future directions:

  • ABAB and InDel Accuracy: While improved, the accuracy for ABAB loci and InDels at AAAB and ABAB loci could still be enhanced.
  • Improving the Bayesian Model: The Bayesian model could be further refined by incorporating additional features, such as fragment size and preferred ending positions of fetal cfDNA fragments, to better distinguish fetal from maternal reads.
  • Scalability and Clinical Feasibility: The authors suggest that as genome-wide direct phasing becomes more accessible and cost-effective, their method could become more widely adopted. Further work on increasing clinical feasibility is also warranted.
  • De Novo Variants and X-linked Inheritance: While the paper doesn't explicitly state limitations for these, previous Bayesian methods have struggled with de novo variants and X-linked inheritance, which might be areas for future investigation with this combined approach.

Summary updated

Abstract

<b>Background:</b> Non-invasive prenatal diagnosis (NIPD) can identify monogenic diseases early during pregnancy with negligible risk to fetus or mother, but the haplotyping methods involved sometimes cannot infer parental inheritance at heterozygous maternal or paternal loci or at loci for which haplotype or genome phasing data are missing. This study was performed to establish a method that can effectively recover the whole fetal genome using maternal plasma cell-free DNA (cfDNA) and parental genomic DNA sequencing data, and validate the method's effectiveness in noninvasively detecting single nucleotide variations (SNVs), insertions and deletions (indels). <b>Methods:</b> A Bayesian model was developed to determine fetal genotypes using the plasma cfDNA and parental genomic DNA from five couples of healthy pregnancy. The Bayesian model was further integrated with a haplotype-based method to improve the inference accuracy of fetal genome and prediction outcomes of fetal genotypes. Five pregnancies with high risks of monogenic diseases were used to validate the effectiveness of this haplotype-assisted Bayesian approach for noninvasively detecting indels and pathogenic SNVs in fetus. <b>Results:</b> Analysis of healthy fetuses led to the following accuracies of prediction: maternal homozygous and paternal heterozygous loci, 96.2 ± 5.8%; maternal heterozygous and paternal homozygous loci, 96.2 ± 1.4%; and maternal heterozygous and paternal heterozygous loci, 87.2 ± 4.7%. The respective accuracies of predicting insertions and deletions at these types of loci were 94.6 ± 1.9%, 80.2 ± 4.3%, and 79.3 ± 3.3%. This approach detected pathogenic single nucleotide variations and deletions with an accuracy of 87.5% in five fetuses with monogenic diseases. <b>Conclusions:</b> This approach was more accurate than methods based only on Bayesian inference. Our method may pave the way to accurate and reliable NIPD.
BibTeX
@inproceedings{li2022non,
  author = {Jia Li and Jiaqi Lu and Fengxia Su and Jiexia Yang and Jia Ju and Yu Lin and Jinjin Xu and Yiming Qi and Yaping Hou and Jing Wu and Wei He and Zhengtao Yang and Yujing Wu and Zhuangyuan Tang and Ying‐Ping Huang and Guohong Zhang and Ying Yang and Long Zhou and Xiaofang Cheng and Ping Liu and Jun Xia and Yanyan Zhang and Yicong Wang and Fang Chen and Jianguo Zhang and Lijian Zhao and Xin Jin and Ya Gao and Aihua Yin},
  title = {{Non-Invasive Prenatal Diagnosis of Monogenic Disorders Through Bayesian- and Haplotype-Based Prediction of Fetal Genotype}},
  booktitle = {Frontiers in Genetics},
  year = {2022},
  doi = {10.3389/fgene.2022.911369},
}
Figure